Brunetta et al. found that PTX3 emerged as a strong independent predictor of 28-day mortality in a multivariable analysis, better than conventional markers of inflammation, in hospitalized patients with COVID-19 [18]. This evidence concerns the gene PTX3 and COVID-19.